Literature DB >> 18366946

The role of safer injection facilities in the response to HIV/AIDS among injection drug users.

Thomas Kerr1, Jo Kimber, Kora Debeck, Evan Wood.   

Abstract

Many cities throughout the globe are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDUs). In particular, HIV has become endemic among IDUs in many settings. In an effort to reduce this and related public health concerns, medically supervised safer injecting facilities (SIFs), where IDUs can inject pre-obtained illicit drugs under the supervision of medical staff, have been established in several countries. The following review assesses the role that SIFs can play in reducing the harms associated with HIV infection among IDUs and points to ways in which SIFs can be further developed to better respond to the challenges associated with HIV/AIDS among this population.

Entities:  

Mesh:

Year:  2007        PMID: 18366946     DOI: 10.1007/s11904-007-0023-8

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  36 in total

Review 1.  Structural interventions to reduce HIV transmission among injecting drug users.

Authors:  D C Des Jarlais
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

2.  Assessing the impact of an adult day program on hospital utilization by persons living with HIV/AIDS.

Authors:  Thomas Kerr; Kevin J Craib; Nada Gataric; Robert S Hogg
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

3.  High rates of primary care and emergency department use among injection drug users in Vancouver.

Authors:  T Kerr; E Wood; E Grafstein; T Ishida; K Shannon; C Lai; J Montaner; M W Tyndall
Journal:  J Public Health (Oxf)       Date:  2004-11-25       Impact factor: 2.341

4.  Attendance at supervised injecting facilities and use of detoxification services.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

5.  Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Authors:  Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Public Health (Oxf)       Date:  2007-01-17       Impact factor: 2.341

6.  Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Authors:  Steven Petrar; Thomas Kerr; Mark W Tyndall; Ruth Zhang; Julio S G Montaner; Evan Wood
Journal:  Addict Behav       Date:  2006-08-22       Impact factor: 3.913

7.  Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm.

Authors:  Tim Rhodes; Jo Kimber; Will Small; John Fitzgerald; Thomas Kerr; Matthew Hickman; Greg Holloway
Journal:  Addiction       Date:  2006-10       Impact factor: 6.526

8.  Do supervised injecting facilities attract higher-risk injection drug users?

Authors:  Evan Wood; Mark W Tyndall; Kathy Li; Elisa Lloyd-Smith; Will Small; Julio S G Montaner; Thomas Kerr
Journal:  Am J Prev Med       Date:  2005-08       Impact factor: 5.043

9.  Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.

Authors:  Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Aslam H Anis; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

10.  A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.

Authors:  Thomas Kerr; Will Small; David Moore; Evan Wood
Journal:  Int J Drug Policy       Date:  2007-01-16
View more
  18 in total

1.  Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

Authors:  Hudson Reddon; Evan Wood; Mark Tyndall; Calvin Lai; Robert Hogg; Julio Montaner; Thomas Kerr
Journal:  AIDS Educ Prev       Date:  2011-10

2.  Drug use in business bathrooms: An exploratory study of manager encounters in New York City.

Authors:  Brett Wolfson-Stofko; Alex S Bennett; Luther Elliott; Ric Curtis
Journal:  Int J Drug Policy       Date:  2016-10-18

3.  The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges.

Authors:  Kora Debeck; Thomas Kerr
Journal:  Open Med       Date:  2010-09-21

4.  Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.

Authors:  Steffanie A Strathdee; Jamila K Stockman
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

Review 5.  HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Salaam Semaan; Evan Wood
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

6.  Canada's highest court unchains injection drug users; implications for harm reduction as standard of healthcare.

Authors:  Dan Small
Journal:  Harm Reduct J       Date:  2012-07-20

7.  An appeal to humanity: legal victory in favour of North America's only supervised injection facility: Insite.

Authors:  Dan Small
Journal:  Harm Reduct J       Date:  2010-10-09

8.  Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage.

Authors:  Dan Small
Journal:  Harm Reduct J       Date:  2008-10-28

9.  'On the same level': facilitators' experiences running a drug user-led safer injecting education campaign.

Authors:  Cody Callon; Grant Charles; Rick Alexander; Will Small; Thomas Kerr
Journal:  Harm Reduct J       Date:  2013-03-06

10.  Improving community health and safety in Canada through evidence-based policies on illegal drugs.

Authors:  Evan Wood; Moira McKinnon; Robert Strang; Perry R Kendall
Journal:  Open Med       Date:  2012-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.